226 related articles for article (PubMed ID: 25959844)
1. A comparison of ED and direct admission care of cancer patients with febrile neutropenia.
Owolabi DK; Rowland R; King L; Miller R; Hegde GG; Shang J; Lister J; Venkat A
Am J Emerg Med; 2015 Jul; 33(7):966-9. PubMed ID: 25959844
[TBL] [Abstract][Full Text] [Related]
2. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
[TBL] [Abstract][Full Text] [Related]
3. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.
Kumar P; Bajpai J; Shetty N; Medekar A; Kurkure PA; Ghadyalpatil N; Gupta S; Noronha V; Kanujia A; Parikh P; Banavali SD
Indian J Cancer; 2014; 51(4):491-5. PubMed ID: 26842174
[TBL] [Abstract][Full Text] [Related]
4. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
Keng MK; Thallner EA; Elson P; Ajon C; Sekeres J; Wenzell CM; Seastone DJ; Gallagher EM; Weber CM; Earl MA; Mukherjee S; Pohlman B; Cober E; Foster VB; Yuhas J; Kalaycio ME; Bolwell BJ; Sekeres MA
J Oncol Pract; 2015 Nov; 11(6):450-5. PubMed ID: 26220930
[TBL] [Abstract][Full Text] [Related]
5. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
Lynn JJ; Chen KF; Weng YM; Chiu TF
Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
Ahn S; Rice TW; Yeung SJ; Cooksley T
Support Care Cancer; 2018 May; 26(5):1465-1470. PubMed ID: 29168032
[TBL] [Abstract][Full Text] [Related]
8. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department.
Peyrony O; Gerlier C; Barla I; Ellouze S; Legay L; Azoulay E; Chevret S; Fontaine JP
PLoS One; 2020; 15(2):e0229828. PubMed ID: 32109264
[TBL] [Abstract][Full Text] [Related]
10. Management of febrile neutropenia in an acute oncology service.
Sammut SJ; Mazhar D
QJM; 2012 Apr; 105(4):327-36. PubMed ID: 22080099
[TBL] [Abstract][Full Text] [Related]
11. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
Uys A; Rapoport BL; Anderson R
Support Care Cancer; 2004 Aug; 12(8):555-60. PubMed ID: 15197637
[TBL] [Abstract][Full Text] [Related]
12. An audit of febrile neutropenia cases from a rural cancer center in India.
Patil VM; Chakarborty S; Kumar MS; Geetha M; Dev S; Samuel S; Ahmed G; Nayanar SK; Vineetha R; Nair CK
Indian J Cancer; 2014; 51(4):487-90. PubMed ID: 26842173
[TBL] [Abstract][Full Text] [Related]
13. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
14. Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study.
Nirenberg A; Mulhearn L; Lin S; Larson E
Oncol Nurs Forum; 2004 Jul; 31(4):711-5. PubMed ID: 15252427
[TBL] [Abstract][Full Text] [Related]
15. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
Pettit N; Boadu D; Bischof JJ
Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
[TBL] [Abstract][Full Text] [Related]
16. Febrile neutropenia: median door-to-needle time - results of an initial audit.
Ali N; Baqir M; Hamid A; Khurshid M
Hematology; 2015 Jan; 20(1):26-30. PubMed ID: 24724830
[TBL] [Abstract][Full Text] [Related]
17. Emergency Department evaluation of patients with fever and chemotherapy-induced neutropenia.
Perrone J; Hollander JE; Datner EM
J Emerg Med; 2004 Aug; 27(2):115-9. PubMed ID: 15261351
[TBL] [Abstract][Full Text] [Related]
18. Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.
Nguyen M; Jacobson T; Torres J; Wann A
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1345. PubMed ID: 33635593
[TBL] [Abstract][Full Text] [Related]
19. FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA.
Assefa S; Alemayehu T; Abebe W
Ethiop Med J; 2017 Jan; 55(1):43-7. PubMed ID: 29148638
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
